cilazapril, anhydrous has been researched along with Atrial Fibrillation in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, SJ; Han, W; Huang, YL; Li, WM; Li, Y; Liang, ZJ; Wu, DL | 1 |
| Han, W; Huang, YL; Li, WM; Li, Y; Xie, BD; Zhao, JY | 1 |
| Dong, D; Han, W; Li, B; Li, W; Li, Y; Sheng, L; Xue, J; Yang, B; Yang, S | 1 |
| Chu, S; Dong, D; Gong, YT; Han, W; Li, BX; Li, WM; Li, Y; Liu, W; Sheng, L; Xue, JY; Yang, BF; Zhang, L | 1 |
4 other study(ies) available for cilazapril, anhydrous and Atrial Fibrillation
| Article | Year |
|---|---|
[Effect of Cilazapril on endothelial cell function and fibrinolysis system in the canine atrial fibrillation models].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Fibrillation; Cilazapril; Disease Models, Animal; Dogs; Endothelial Cells; Female; Fibrinolysis; Immunohistochemistry; Male; Plasminogen Activator Inhibitor 1; Tissue Plasminogen Activator | 2005 |
Effects of cilazapril on endothelial cell function and fibrinolysis system in atrial fibrillation.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Fibrillation; Cilazapril; Dogs; Echocardiography; Endothelial Cells; Fibrinolysis; Nitric Oxide; Plasminogen Activator Inhibitor 1; Tissue Plasminogen Activator | 2005 |
Effects of Cilazapril on atrial electrical, structural and functional remodeling in atrial fibrillation dogs.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Fibrillation; Cilazapril; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Female; Heart Atria; Heart Conduction System; Male; Recovery of Function; Treatment Outcome; Ultrasonography | 2007 |
The effects of cilazapril and valsartan on the mRNA and protein expressions of atrial calpains and atrial structural remodeling in atrial fibrillation dogs.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Fibrillation; Blotting, Western; Calpain; Cilazapril; Disease Models, Animal; Dogs; Female; Gene Expression; Gene Expression Regulation; Heart Atria; Male; Myocytes, Cardiac; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazoles; Ultrasonography; Valine; Valsartan | 2007 |